Psychopharmacology and Psychiatry Updates

265 Episodes

1. Tips for Treating Perimenopausal Depression

   Published: 11/28/2021
2. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

   Published: 11/23/2021
3. Subclinical Hypothyroidism in Depressed Adolescents

   Published: 11/18/2021
4. Principles for Managing Alcohol Use Disorder

   Published: 11/13/2021
5. ECT for Depressed Patients With Borderline Personality Disorder

   Published: 11/8/2021
6. Assessing and Treating Alcohol Withdrawal

   Published: 11/3/2021
7. Lab Tests in Psychopharmacology

   Published: 10/29/2021
8. Technology-Facilitated Adherence Enhancement and Family Involvement

   Published: 10/24/2021
9. Drug-Induced Hyperthermic Syndromes in Psychiatry

   Published: 10/19/2021
10. How to Improve Adherence: Targeting Reasons for Nonadherence

    Published: 10/14/2021
11. Esketamine: Postmarketing Safety Concerns

    Published: 10/9/2021
12. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Published: 10/4/2021
13. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Published: 9/29/2021
14. How to Assess Psychotropic Drug Adherence

    Published: 9/24/2021
15. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Published: 9/19/2021
16. Delirium, Catatonia, and COVID-19

    Published: 9/14/2021
17. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Published: 9/9/2021
18. Dopamine and Depression: Clinical Considerations

    Published: 9/4/2021
19. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Published: 8/30/2021
20. New Somatic Treatments for Child and Adolescent Depression

    Published: 8/25/2021